Edwards Lifesciences Corporation
Hedge Funds Holdings
Last updated:
Edwards Lifesciences Corporation‘s stocks are currently a part of 1263 hedge funds’ portfolios, which represents 79.26% of the total amount of its stocks outstanding. This makes up a total of 500.29M shares of Edwards Lifesciences Corporation. Compared to the previous quarter, the number fell by -2.73% or -14.02M shares fewer. As for the holding position changes, 36.1% (456) of current hedge fund investors increased the number of shares held, 36.18% (457) of current holders sold a part of the shares held, and 9.74% (123) closed the holdings completely. 131 hedge funds are new holders of Edwards Lifesciences Corporation stock in Q1 2022, it is 10.37% of total holders.
Hedge funds holding Edwards Lifesciences (Q2 2017 – Q1 2022)
| Q2 2017 | 720 |
|---|---|
| Q3 2017 | 732 |
| Q4 2017 | 768 |
| Q1 2018 | 809 |
| Q2 2018 | 830 |
| Q3 2018 | 849 |
| Q4 2018 | 866 |
| Q1 2019 | 917 |
| Q2 2019 | 913 |
| Q3 2019 | 951 |
| Q4 2019 | 1,077 |
| Q1 2020 | 999 |
| Q2 2020 | 1,022 |
| Q3 2020 | 1,059 |
| Q4 2020 | 1,127 |
| Q1 2021 | 1,112 |
| Q2 2021 | 1,157 |
| Q3 2021 | 1,195 |
| Q4 2021 | 1,283 |
| Q1 2022 | 1,263 |
Hedge funds changes in Edwards Lifesciences positions (Q2 2017 – Q1 2022)
| Q2 2017 | 98 | 224 | 283 | 55 | 60 |
|---|---|---|---|---|---|
| Q3 2017 | 82 | 267 | 259 | 60 | 64 |
| Q4 2017 | 121 | 262 | 267 | 85 | 33 |
| Q1 2018 | 125 | 228 | 305 | 75 | 76 |
| Q2 2018 | 88 | 282 | 307 | 63 | 90 |
| Q3 2018 | 102 | 265 | 319 | 77 | 86 |
| Q4 2018 | 123 | 252 | 330 | 101 | 60 |
| Q1 2019 | 128 | 300 | 325 | 71 | 93 |
| Q2 2019 | 101 | 293 | 350 | 92 | 77 |
| Q3 2019 | 120 | 309 | 347 | 75 | 100 |
| Q4 2019 | 204 | 341 | 351 | 65 | 116 |
| Q1 2020 | 105 | 346 | 397 | 170 | -19 |
| Q2 2020 | 123 | 366 | 362 | 96 | 75 |
| Q3 2020 | 128 | 384 | 368 | 84 | 95 |
| Q4 2020 | 166 | 393 | 383 | 88 | 97 |
| Q1 2021 | 111 | 419 | 351 | 117 | 114 |
| Q2 2021 | 146 | 412 | 383 | 89 | 127 |
| Q3 2021 | 127 | 437 | 396 | 74 | 161 |
| Q4 2021 | 200 | 454 | 404 | 103 | 122 |
| Q1 2022 | 131 | 456 | 457 | 123 | 96 |
Hedge funds changes in Edwards Lifesciences stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 63,772,000 | 95,094,000 |
|---|---|---|
| Q3 2017 | 80,237,000 | 111,810,000 |
| Q4 2017 | 105,722,000 | 3,105,685,000 |
| Q1 2018 | 112,362,000 | 90,351,000 |
| Q2 2018 | 151,532,000 | 136,181,000 |
| Q3 2018 | 373,749,000 | 244,386,000 |
| Q4 2018 | 120,022,000 | 123,796,000 |
| Q1 2019 | 335,382,000 | 307,852,000 |
| Q2 2019 | 177,061,000 | 159,323,000 |
| Q3 2019 | 380,274,000 | 289,107,000 |
| Q4 2019 | 258,940,000 | 261,312,000 |
| Q1 2020 | 168,627,000 | 120,828,000 |
| Q2 2020 | 169,563,038 | 62,151,832,802 |
| Q3 2020 | 100,221,243,150 | 843,151,450,984 |
| Q4 2020 | 138,252,807,284 | 1,117,127,545,883 |
| Q1 2021 | 105,220,000 | 74,620,000 |
| Q2 2021 | 293,498,000 | 169,284,410 |
| Q3 2021 | 249,497,368 | 215,085,770 |
| Q4 2021 | 423,604,355 | 240,633,795 |
| Q1 2022 | 278,670,000 | 188,966,000 |